Herpes Labialis
Showing 1 - 25 of 430
Recurrent Herpes Labialis Trial in Culver City (Acyclovir 50mg buccal tablet, BAYM008894/UI1614773, Placebo)
Recruiting
- Recurrent Herpes Labialis
- Acyclovir 50mg buccal tablet, BAYM008894/UI1614773
- Placebo
-
Culver City, CaliforniaScience 37
Jan 10, 2023
Virus, HSV-1, Herpes Simplex 1 Trial in Pocatello, Saint George (Purell Hand Sanitizer, Medical Grade Mineral Oil)
Recruiting
- Virus
- +3 more
- Purell Hand Sanitizer
- Medical Grade Mineral Oil
-
Pocatello, Idaho
- +2 more
Nov 13, 2023
Herpes Labialis Trial in Germany (drug, behavioral, procedure)
Active, not recruiting
- Herpes Labialis
- HDIT101 (blinded therapy)
- +5 more
-
Berlin, Germany
- +4 more
Jan 26, 2023
Herpes Labialis, HSV Trial in Doral, Saint Paul (Squaric Acid Dibutyl Ester)
Terminated
- Herpes Labialis
- HSV
- Squaric Acid Dibutyl Ester
-
Doral, Florida
- +1 more
Aug 4, 2021
Herpes Labialis Trial in Omaha (Acyclovir 5 percent (Perrigo), Acyclovir 5 percent (Reference), Placebo cream)
Completed
- Herpes Labialis
- Acyclovir 5 percent (Perrigo)
- +2 more
-
Omaha, NebraskaQuality Clinical Research Inc
Oct 20, 2021
Cold Sores Trial in Santa Monica (Herpecin L)
Completed
- Cold Sores
- Herpecin L
-
Santa Monica, CaliforniaCitruslabs
Apr 1, 2023
HSV, Herpes Labialis Trial in Saint Paul (Squaric Acid Dibutyl Ester)
Completed
- HSV
- Herpes Labialis
- Squaric Acid Dibutyl Ester
-
Saint Paul, MinnesotaPrism Clinical Research, LLC
Oct 5, 2021
Herpes Labialis Trial in Chicago (onabotulinumtoxinA, Bacteriostatic normal saline)
Terminated
- Herpes Labialis
- onabotulinumtoxinA
- Bacteriostatic normal saline
-
Chicago, IllinoisDeNova Research
Nov 24, 2020
Recurrent Herpes Labialis Trial (BOR15001L7, Docosanol Cream 10%)
Unknown status
- Recurrent Herpes Labialis
- BOR15001L7
- Docosanol Cream 10%
- (no location specified)
Sep 4, 2020
Photodynamic Therapy, Herpes Simplex, Labial Trial (photodynamic therapy herpes labialis)
Unknown status
- Photodynamic Therapy
- Herpes Simplex, Labial
- photodynamic therapy herpes labialis
- (no location specified)
Dec 24, 2019
Herpes Labialis Trial in Tokyo (New formulation, Current formulation)
Completed
- Herpes Labialis
- New formulation
- Current formulation
-
Tokyo, JapanGSK Investigational Site
Aug 30, 2018
Knowledge of Young Adults About Genital Herpes
Recruiting
- Genital Herpes
- data collection
-
Reims, FranceFanny Bichon
Dec 29, 2022
Disorder of Oral Mucous Membrane Trial in Ann Arbor (EVPOME (autogenous ex vivo produced oral mucosa equivalent), POM (Palatal
Terminated
- Disorder of Oral Mucous Membrane
- EVPOME (autogenous ex vivo produced oral mucosa equivalent)
- POM (Palatal oral mucosa)
-
Ann Arbor, MichiganUniversity of Michigan, Department of Oral & Maxxillofacial Surg
Aug 9, 2021
Herpes Zoster Trial in India (HZ/su, Placebo)
Active, not recruiting
- Herpes Zoster
- HZ/su
- Placebo
-
Visakhapatnam, Andhra Pradesh, India
- +8 more
Jan 6, 2023
HSV Infection Trial (walnut extract)
Completed
- HSV Infection
- walnut extract
- (no location specified)
Oct 16, 2023
Zoster, Systemic Lupus Erythematosus, Vaccine Reaction Trial in Seoul (Shingrix, Placebo)
Recruiting
- Zoster
- +2 more
- Shingrix
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 17, 2023
Neuropathic Pain Trial in Frankfurt am Main (Vitamin C)
Suspended
- Neuropathic Pain
- Vitamin C
-
Frankfurt am Main, Hessen, GermanyUniversitätsklinikum Frankfurt am Main
Oct 4, 2022
Post Herpetic Neuralgia by Ultrasound Guided Single Nerve Block
Withdrawn
- Pain
- Ultrasound guided nerve block
-
Brooklyn, New YorkMaimonides Medical Center
Jun 13, 2022
Oral and Maxillofacial Pathology in Pediatric Patients
Completed
- Mouth Diseases
-
Cairo, EgyptCairo University
Jul 13, 2020
Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +9 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Linyi, Shandong, ChinaLinyi Central Hospital
Jul 25, 2023
Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)
Not yet recruiting
- Herpes Simplex
- HSVTI Formulation 1
- +2 more
-
Tokyo, JapanGSK Investigational Site
Aug 4, 2023
Herpes Zoster Trial (Recombinant Zoster Vaccine, Placebo, Zoster Vaccine Recombinant, Adjuvanted)
Not yet recruiting
- Herpes Zoster
- Recombinant Zoster Vaccine
- +2 more
- (no location specified)
Feb 6, 2023
Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +8 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Jiangsu, ChinaXuzhou Second People's Hospital
May 8, 2023
Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1
Recruiting
- Lung Cancer
- +11 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Anqing, Anhui, ChinaThe PLA Navy Anqing Hospital
May 23, 2023